Andrea Necchi, MD

Andrea Necchi, MD, Medical Oncologist, San Raffaele Hospital and Scientific Institute

Articles by Andrea Necchi, MD

KEYNOTE-057: Pembrolizumab Monotherapy for High-risk NMIBC Unresponsive to BCG

Andrea Necchi, MDASCO GU Symposium 2023 | February 24, 2023

Andrea Necchi, MD, speculates on the applicability of pembrolizumab monotherapy for BCG-unresponsive NMIBC.